PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7720520-4	1995	Furafylline was a potent, mechanism-based inhibitor for CYP1A2-mediated phenacetin O-deethylation.	furafylline	0-11	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	56-62	
7720520-4	1995	Furafylline was a potent, mechanism-based inhibitor for CYP1A2-mediated phenacetin O-deethylation.	Phenacetin	72-82	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	56-62	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	Sulfaphenazole	11-25	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	27-33	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	Sulfaphenazole	11-25	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	50-56	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	Quinidine	39-48	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	50-56	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	Tolbutamide	80-91	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	27-33	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	Tolbutamide	80-91	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	50-56	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	bufuralol	116-125	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	27-33	
7720520-5	1995	The probes sulfaphenazole (CYP2C9) and quinidine (CYP2D6) selectively inhibited tolbutamide methylhydroxylation and bufuralol 1"-hydroxylation, respectively.	bufuralol	116-125	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	50-56	
7720520-6	1995	Additionally, the CYP2E1-catalyzed chlorzoxazone 6-hydroxylation was significantly inhibited by diethyldithiocarbamate.	Chlorzoxazone	35-48	cytochrome P450 family 2 subfamily E member 1	Homo sapiens	18-24	
7720520-6	1995	Additionally, the CYP2E1-catalyzed chlorzoxazone 6-hydroxylation was significantly inhibited by diethyldithiocarbamate.	Ditiocarb	96-118	cytochrome P450 family 2 subfamily E member 1	Homo sapiens	18-24	
7720520-7	1995	Of the CYP3A4 inhibitor probes used, troleandomycin proved to be the most specific for testosterone 6 beta-hydroxylation.	Troleandomycin	37-51	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	7-13	
7720520-7	1995	Of the CYP3A4 inhibitor probes used, troleandomycin proved to be the most specific for testosterone 6 beta-hydroxylation.	Testosterone	87-99	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	7-13